Related Experiment Video
Updated: May 25, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Around-the-clock: Caregiving at night for juveniles living with type 1 diabetes - a systematic review
Vivienne Howard1, Rebecca Maguire2, Enda De Bruin1
1School of Psychology, Trinity College Dublin, Dublin, Ireland.
Insights
Nocturnal caregiving for children with type 1 diabetes (T1D) is common and significantly impacts caregivers
Area of Science:
- Pediatric Endocrinology
- Caregiver Health
- Health Services Research
Background:
- Nocturnal caregiving for children with type 1 diabetes (T1D) is a demanding aspect of family caregiving.
- The impact of this round-the-clock care on caregivers is often overlooked in clinical settings.
Purpose of the Study:
- To systematically review and synthesize research on nocturnal caregiving practices (NCP) for children with T1D.
- To explore the prevalence, nature, and impacts of NCP on caregivers.
- To evaluate technology's role in supporting NCP and identify solutions for burden mitigation.
Main Methods:
- Systematic review of peer-reviewed studies published since 1997, identified through searches of six major databases.
- Inclusion of quantitative, qualitative, and mixed-methods studies addressing NCP for juveniles with T1D.
- Risk of bias analysis and synthesis of quantitative data; thematic analysis of qualitative data.
Main Results:
- 31 studies involving 3,547 caregivers were included; 88% engaged in NCP.
- Over 50% of caregivers experienced inadequate sleep, and 54% reported poor sleep quality.
- Adverse impacts included exhaustion, decision-making difficulties, and negative effects on mood and physical health; technology benefits were equivocal.
Conclusions:
- Nocturnal caregiving for children with T1D is pervasive and significantly affects caregiver well-being.
- Current clinical practice rarely addresses the sleep needs of these caregivers.
- Recommendations include modifying care guidelines and developing psychosocial supports to acknowledge and mitigate the burden of NCP.
Abstract:
Caring for children with type 1 diabetes (T1D) can require around-the-clock attention but there is little acknowledgment of the impact that nocturnal caregiving can have on caregivers in clinical care provision. This systematic review aimed to (1) explicate nocturnal caregiving practice (NCP) by identifying and synthesising peer-reviewed research to establish the prevalence and nature of NCP, (2) explore the impacts of NCP for caregivers, (3) evaluate the perceived value of technology for supporting NCP, and (4) examine potential solutions for mitigating NCP burden. In January, 2022, the databases CINAHL, MEDLINE, Web of Science, PsycINFO, Scopus and EMBASE were searched to identify peer-reviewed studies, published in English since 1997, which addressed NCP for juveniles with T1D. Quantitative, qualitative and mixed-methods studies were included. Risk of bias analysis was carried out using the quality assessment with diverse studies tool. Where possible, quantitative data were aggregated. Qualitative data was subjected to a narrative synthesis, using thematic analysis. Thirty-one studies met inclusion criteria, comprising 3,547 caregivers. 88% of caregivers engaged in NCP, though frequency was variable. Over 50% of participants (19-80%) failed to get adequate sleep and 54% reported poor sleep quality. Qualitative testimony detailed adverse impacts of NCP; exhaustion, difficulty making illness-management decisions, negative impacts on mood and physical health. Benefits from technology were equivocal. Evidence regarding predictors and associations for NCP, such as patient age, was contradictory. 83% of authors recommended that sleep be routinely addressed in clinic, which is not current practice. This review provides clear evidence that NCP in T1D is pervasive with significant negative impacts on caregivers. These secondary impacts of juvenile T1D need to be acknowledged so that care guidelines can be modified and psychosocial supports can be developed for use in clinical treatment environments.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

